Skaya Pharma Private Limited
About Skaya Pharma Private Limited
Data last updated:
Skaya Pharma Private Limited is a private limited company based in Satara, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 06 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74990PN2018PTC180592. Its GSTIN is 27ABBCS2356N1ZZ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ambadas Narsingrao Kadam and Sanjeevani Ambadas Kadam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Satara, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.07 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹78,720 (net margin 2.3%) and EBITDA of ₹1.63 Lakh (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 29% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Skaya Pharma Private Limited's registered office is in Satara, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.1 Sadanand Dham Nishigandha Colony, Samarth Nagar, Satara, Maharashtra, India – 415002
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Skaya Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Skaya Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Skaya Pharma Private Limited, buy the company report.
Financials of Skaya Pharma Private Limited
FY 2025 filings availableSkaya Pharma Private Limited reported revenue of ₹34.07 Lakh (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 1% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹78,720 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Skaya Pharma Private Limited, buy the company report.
Board of directors of Skaya Pharma Private Limited
Skaya Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ambadas Narsingrao Kadam | Director | 06 Dec 2018 | 7 Years 10 Months | Current |
| Sanjeevani Ambadas Kadam | Director | 06 Dec 2018 | 7 Years 10 Months | Current |
Peer comparison
Skaya Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shreya Nursing & Healthcare Private Limited | ₹34.21 Lakh (FY 2023) | 20.0% | Moradabad, Uttar Pradesh, India | |||
| Life Junction Foundation | ₹34.2 Lakh (FY 2022) | Kankarbagh, Patna, Bihar, India | ||||
| Adyant Healthcare Private Limited | ₹34.19 Lakh (FY 2023) | -6.0% | Hyderabad, Telangana, India | |||
| Chennai School of Music Therapy Private Limited | ₹34.15 Lakh (FY 2024) | 76.0% | Chennai, Tamil Nadu, India | |||
| Grace & Harry Healthcare Private Limited | ₹34.09 Lakh (FY 2023) | 76.0% | Chennai, Tamil Nadu, India | |||
| Skaya Pharma Private Limitedthis company | ₹34.07 Lakh (FY 2025) | ₹78,720 | 2.3% | 1.0% | Satara, Maharashtra, India | |
| Global Cancer Hub (Indore) Private Limited | ₹34.05 Lakh (FY 2025) | 98.0% | Indore, Madhya Pradesh, India | |||
| Oxford CT Scan Centre Private Limited | ₹34.03 Lakh (FY 2024) | -28.0% | Ranchi, Jharkhand, India | |||
| Royal Cosmognathic Private Limited | ₹34.03 Lakh (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Austin Laboratories India Private Limited | ₹34.03 Lakh (FY 2019) | -36.0% | Bangalore, Karnataka, India | |||
| P R Medication Private Limited | ₹34.03 Lakh (FY 2021) | 8.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Skaya Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Skaya Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Skaya Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Skaya Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABBCS2356N1ZZ | Maharashtra | Active | 11 Sep 2019 |
To see the full GST registrations and return filing status of Skaya Pharma Private Limited, buy the company report.
Recent activity
Skaya Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Ambadas Narsingrao Kadam was appointed as Director on 06 Dec 2018.
Frequently asked questions
Skaya Pharma is an active private limited company based in Satara, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 06 December 2018 (8+ years old) and is registered under CIN U74990PN2018PTC180592.
Skaya Pharma has 2 current directors:
- Ambadas Narsingrao Kadam - Director
- Sanjeevani Ambadas Kadam - Director
The latest financial statements of Skaya Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Skaya Pharma is 27ABBCS2356N1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Skaya Pharma is U74990PN2018PTC180592. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Skaya Pharma was incorporated on 06 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Skaya Pharma by revenue are Shreya Nursing & Healthcare Private Limited, Life Junction Foundation, Adyant Healthcare Private Limited, Chennai School of Music Therapy Private Limited, Grace & Harry Healthcare Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Ambadas Narsingrao Kadam was appointed as Director on 06 Dec 2018. Sanjeevani Ambadas Kadam was appointed as Director on 06 Dec 2018.
The registered office of Skaya Pharma is at Plot No.1 Sadanand Dham Nishigandha Colony, Samarth Nagar, Satara, Maharashtra, India – 415002.
Skaya Pharma operates in the business services industry, in the other services segment.
The compliance status of Skaya Pharma is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
